JP2013523749A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523749A5
JP2013523749A5 JP2013502740A JP2013502740A JP2013523749A5 JP 2013523749 A5 JP2013523749 A5 JP 2013523749A5 JP 2013502740 A JP2013502740 A JP 2013502740A JP 2013502740 A JP2013502740 A JP 2013502740A JP 2013523749 A5 JP2013523749 A5 JP 2013523749A5
Authority
JP
Japan
Prior art keywords
quinolin
phenyl
hydroxy
hydroxythieno
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013502740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523749A (ja
JP5849302B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/030278 external-priority patent/WO2011123419A1/en
Publication of JP2013523749A publication Critical patent/JP2013523749A/ja
Publication of JP2013523749A5 publication Critical patent/JP2013523749A5/ja
Application granted granted Critical
Publication of JP5849302B2 publication Critical patent/JP5849302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013502740A 2010-03-29 2011-03-29 三環化合物およびこれを含有するpbk阻害剤 Active JP5849302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31860610P 2010-03-29 2010-03-29
US61/318,606 2010-03-29
PCT/US2011/030278 WO2011123419A1 (en) 2010-03-29 2011-03-29 Trycyclic compounds and pbk inhibitors containing the same

Publications (3)

Publication Number Publication Date
JP2013523749A JP2013523749A (ja) 2013-06-17
JP2013523749A5 true JP2013523749A5 (enExample) 2014-05-15
JP5849302B2 JP5849302B2 (ja) 2016-01-27

Family

ID=44712585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013502740A Active JP5849302B2 (ja) 2010-03-29 2011-03-29 三環化合物およびこれを含有するpbk阻害剤

Country Status (15)

Country Link
US (2) US8962648B2 (enExample)
EP (1) EP2552206B1 (enExample)
JP (1) JP5849302B2 (enExample)
KR (1) KR101757502B1 (enExample)
CN (1) CN102917590B (enExample)
AU (1) AU2011235319B2 (enExample)
BR (1) BR112012023836B1 (enExample)
CA (1) CA2792941C (enExample)
DK (1) DK2552206T3 (enExample)
ES (1) ES2547571T3 (enExample)
IL (1) IL222080B (enExample)
MX (1) MX2012011412A (enExample)
SG (1) SG184376A1 (enExample)
TW (1) TWI503323B (enExample)
WO (1) WO2011123419A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201990240A1 (ru) * 2013-12-24 2019-06-28 Бристол-Маерс Сквибб Компани Новые трициклические соединения в качестве противораковых средств
TWI557011B (zh) 2015-05-25 2016-11-11 可影像處理的自行車錶裝置
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
GB201617758D0 (en) 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds
CN108341774B (zh) * 2017-01-25 2022-07-19 首药控股(北京)股份有限公司 取代的喹啉酮类抑制剂
PE20191616A1 (es) 2017-04-10 2019-11-05 Bayer Ag N-ariletil-2-arilquinolina-4-carboxamidas sustituidas y su uso
WO2019094404A1 (en) * 2017-11-07 2019-05-16 Temple University-Of The Commonwealth System Of Higher Education Compositions and methods for improved t cells
CN111099941B (zh) * 2018-10-26 2022-10-18 中国科学院上海有机化学研究所 一种烷基腈类化合物的制备方法
CN116490507A (zh) 2020-09-10 2023-07-25 薛定谔公司 用于治疗癌症的杂环包缩合cdc7激酶抑制剂
CN117120447A (zh) * 2021-03-18 2023-11-24 薛定谔公司 环状化合物和其使用方法
TW202300150A (zh) * 2021-03-18 2023-01-01 美商薛定諤公司 環狀化合物及其使用方法
CN117362304A (zh) * 2022-07-07 2024-01-09 深圳微芯生物科技股份有限公司 一种甲酰胺取代的杂三环类衍生物、其制备方法及其应用
WO2024097228A1 (en) * 2022-10-31 2024-05-10 Meliora Therapeutics, Inc. Compounds targeting cdk11 and methods of using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377096A (en) * 1976-12-17 1978-07-08 Teijin Ltd Preparation of thieno 2,3-c quinolin-4(5h)-one-7-acetic acids
FR2636063B1 (fr) * 1988-09-05 1993-04-30 Centre Nat Rech Scient Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application
DE19806348A1 (de) * 1998-02-12 1999-08-19 Schering Ag 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
US6506769B2 (en) 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
BR0016878A (pt) * 1999-12-29 2002-10-08 Wyeth Corp Inibidores tricìclicos de cinases protéicas
DE10242106A1 (de) 2002-09-11 2004-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Phosphorgruppenhaltige Carbonsäurederivate mit organisch polymerisierbaren Gruppen
EA200500342A1 (ru) * 2002-09-17 2005-08-25 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Гетероциклические замещённые пиперазины для лечения шизофрении
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
GB0501999D0 (en) * 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
DK2061765T3 (en) * 2006-09-01 2015-01-26 Senhwa Biosciences Inc Serine-threonine protein kinase AND PARP-MODULATOR
CN101754974B (zh) 2007-07-19 2016-02-03 Msd意大利有限公司 作为抗病毒剂的大环化合物
CN102036561A (zh) * 2008-02-29 2011-04-27 赛林药物股份有限公司 蛋白激酶调节剂

Similar Documents

Publication Publication Date Title
JP6831450B2 (ja) Gpr119アゴニストとしてのチアゾロピリジン誘導体
ES2441196T3 (es) Derivado de anillo condensado nitrogenado, composiciones farmacéuticas que lo contienen, y su uso con fines médicos
EP2925757B1 (en) Compounds and compositions for the treatment of parasitic diseases
ES2638850T3 (es) Compuestos de azabenzimidazol como inhibidores de las isoenzimas de la PDE4 para el tratamiento de trastornos del SNC y otros trastornos
KR20020063934A (ko) 코르티코트로핀 방출 인자 길항제
TWI839524B (zh) 抑制jak激酶1的新型化合物
KR101757502B1 (ko) 트리시클릭 화합물 및 이를 함유하는 pbk 저해제
TWI440639B (zh) 作為trpv1調節劑之四氫-嘧啶并氮呯類
CN103313987A (zh) 吡唑并吡啶化合物、吡唑并吡啶化合物以及它们作为tyk2抑制剂的用途
KR20120124428A (ko) 치환된 피롤로-아미노피리미딘 화합물
TW201927757A (zh) 作為parp14抑制劑之喹唑啉酮
WO2003053446A1 (en) Thienopyrimidine compounds as protein tyrosine kinase inhibitors
NZ285442A (en) Corticotropin-releasing factor antagonists comprising pyridines, pyrimidines, purinoses, pyrrolopyrimidinones and pyrrolopyridinone compounds
TW200940539A (en) RAF inhibitor compounds and methods of use thereof
CN101006086A (zh) 用于治疗癌症的5-氨基-2,4,7-三氧代-3,4,7,8-四氢-2H-吡啶并[2,3-d]嘧啶衍生物和相关化合物
CN103209695A (zh) 氮杂苯并噻唑化合物、组合物及应用方法
TWI918753B (zh) 嘧啶化合物、組合物及其醫藥應用
JP2009523805A (ja) TNFα、PDE4及びB−RAFの阻害剤、それらの組成物及びそれらの使用法
CN114206853A (zh) 用于治疗的parp14的靶向蛋白质降解
CN101027305A (zh) 稠合杂环型激酶抑制剂
TW202039446A (zh) 雜環化合物
JP7774573B2 (ja) トリアゾロン化合物
EP2825537B1 (en) Dihydropyridopyrimidine and dihydronaphthyridine derivatives as tyrosine kinase inhibitors of especially vegf and pdgf
WO2024175998A1 (en) Benzenesulfonamide derivatives and uses thereof
WO2023126951A1 (en) Inhibitors of autophagy-related protein-protein interactions